Form 4 for KALA KALA BIO, Inc.
Accepted 2023-06-02 00:00:00 ET · period of report 2023-05-31 · accession 0001415889-23-009143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-02 | 2023-05-31 | KALA | Farid Marjan | Dir | A - Grant | — | +1,600 | 1,600 | New | — |
| D | 2023-06-02 | 2023-05-31 | KALA | Farid Marjan | Dir | D - Sale to Iss | — | -1,600 | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-31 | A | A | 1,600 | — | 1,600 | D | — | — | (F1) On May 31, 2023, the issuer canceled, pursuant to the issuer's option exchange program, all outstanding unexercised options granted to the reporting person. In exchange for the unvested options, the reporting person received a grant of 1,600 RSUs that vest over three years, with 86% of such RSUs vesting on May 31, 2025 and 14% of such RSUs vesting on May 31, 2026, in each case, subject to the reporting person's continued service with the issuer. Each RSU represents a contingent right to receive one share of the issuer's common stock. (F2) Includes 1,600 unvested RSUs. |
| 2 | Derivative | Stock Option (right to buy) | 2023-05-31 | D | D | 1,600 | — | 0 | D | $6.35 · — to 2032-10-30 | 1,600 Common Stock | (F1) On May 31, 2023, the issuer canceled, pursuant to the issuer's option exchange program, all outstanding unexercised options granted to the reporting person. In exchange for the unvested options, the reporting person received a grant of 1,600 RSUs that vest over three years, with 86% of such RSUs vesting on May 31, 2025 and 14% of such RSUs vesting on May 31, 2026, in each case, subject to the reporting person's continued service with the issuer. Each RSU represents a contingent right to receive one share of the issuer's common stock. (F3) The cancelled option was granted on October 31, 2022 and provided for vesting with respect to 1/3rd of the shares underlying the option on October 31, 2023 and as to an additional 1/36th of the shares underlying the option at the end of each successive one-month period thereafter until October 31, 2025. |